Company registration number 09983843 (England and Wales)
TAUNTON DOCTORS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
TAUNTON DOCTORS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
TAUNTON DOCTORS LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
201,665
116,875
Investments
5
20,001
54,101
221,666
170,976
Current assets
Stocks
300
300
Debtors
6
149,870
976,832
Cash at bank and in hand
83,051
3,421
233,221
980,553
Creditors: amounts falling due within one year
7
(200,725)
(24,270)
Net current assets
32,496
956,283
Total assets less current liabilities
254,162
1,127,259
Creditors: amounts falling due after more than one year
8
(79,423)
(66,690)
Provisions for liabilities
(19,633)
(21,172)
Net assets
155,106
1,039,397
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
154,106
1,038,397
Total equity
155,106
1,039,397
TAUNTON DOCTORS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 18 December 2025 and are signed on its behalf by:
Dr T A Norbury
Director
Company registration number 09983843 (England and Wales)
TAUNTON DOCTORS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Taunton Doctors Limited is a private company limited by shares incorporated in England and Wales. The registered office is Victoria Gate, East Reach, Taunton, Somerset, TA1 3EX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
15% straight line
Fixtures and fittings
15% straight line
Motor vehicles
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

TAUNTON DOCTORS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.8
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

TAUNTON DOCTORS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
4
5
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024
159,289
Additions
117,975
At 31 March 2025
277,264
Depreciation and impairment
At 1 April 2024
42,414
Depreciation charged in the year
33,185
At 31 March 2025
75,599
Carrying amount
At 31 March 2025
201,665
At 31 March 2024
116,875
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
20,001
54,101
TAUNTON DOCTORS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
5
Fixed asset investments
(Continued)
- 6 -
Movements in fixed asset investments
Shares in subsidiaries and associates
£
Cost or valuation
At 1 April 2024 & 31 March 2025
54,101
Impairment
At 1 April 2024
-
Disposals
34,100
At 31 March 2025
34,100
Carrying amount
At 31 March 2025
20,001
At 31 March 2024
54,101
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
21,274
49,795
Other debtors
128,596
927,037
149,870
976,832

Included within other debtors are balances totalling £127,376 (2024 - £890,542) owing from related parties. Outstanding balances are unsecured, interest free and deemed repayable upon demand.

7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
17,367
3,461
Other creditors
183,358
20,809
200,725
24,270

Included within other creditors are balances totalling £17,979 (2024 - £13,570) relating to amounts owed under hire purchase contracts. Hire purchase contracts are secured over assets of the company.

Included within other creditors are balances totalling £105,129 (2024 - £Nil) owing to a former subsidiary of the company. Outstanding balances are unsecured, interest free and deemed repayable upon demand.

TAUNTON DOCTORS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
79,423
66,690

Included within other creditors are balances totalling £79,423 (2024 - £66,690) relating to amounts owed under hire purchase contracts. Hire purchase contracts are secured over assets of the company.

9
Financial commitments, guarantees and contingent liabilities

Contingent liability

The company is guarantor for some energy contracts supplied to non-associated entities that are due to expire in the next 3-5 years. Those contracts that the company has a greater than 50% chance of being liable for due to defaults by the non-associated entities are provided for in these financial statements.

 

The potential liability resulting from the remaining contracts with a chance of less than 50% of default and therefore being liable for cannot be reliably estimated, but could be in the region of between nil and approximately £100,000. This risk will only arise should those entities (limited companies and unlimited partnerships) default on their energy contracts and the risk is deemed to be remote by the directors.

 

10
Related party transactions
Transactions with related parties

During the year SD Pharmacy Limited (a subsidiary of the company) was sold. At the time of the disposal it was owing an intercompany loan to the company which totalled £896,722 which has been written off within this years financial statements.

11
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts repaid
Closing balance
£
£
£
1 Director
-
20,740
(20,740)
-
20,740
(20,740)
-

The balances are unsecured, interest free and repayable on demand.

2025-03-312024-04-01falsefalsefalse19 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityDr T A NorburyDr C HornungDr W J HarrisDr S Johnson099838432024-04-012025-03-31099838432025-03-31099838432024-03-3109983843core:OtherPropertyPlantEquipment2025-03-3109983843core:OtherPropertyPlantEquipment2024-03-3109983843core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3109983843core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3109983843core:WithinOneYear2025-03-3109983843core:WithinOneYear2024-03-3109983843core:AfterOneYear2025-03-3109983843core:AfterOneYear2024-03-3109983843core:CurrentFinancialInstruments2025-03-3109983843core:CurrentFinancialInstruments2024-03-3109983843core:ShareCapital2025-03-3109983843core:ShareCapital2024-03-3109983843core:RetainedEarningsAccumulatedLosses2025-03-3109983843core:RetainedEarningsAccumulatedLosses2024-03-3109983843bus:Director12024-04-012025-03-3109983843core:PlantMachinery2024-04-012025-03-3109983843core:FurnitureFittings2024-04-012025-03-3109983843core:MotorVehicles2024-04-012025-03-31099838432023-04-012024-03-3109983843core:OtherPropertyPlantEquipment2024-03-3109983843core:OtherPropertyPlantEquipment2024-04-012025-03-3109983843core:Non-currentFinancialInstruments2025-03-3109983843core:Non-currentFinancialInstruments2024-03-3109983843bus:PrivateLimitedCompanyLtd2024-04-012025-03-3109983843bus:FRS1022024-04-012025-03-3109983843bus:AuditExemptWithAccountantsReport2024-04-012025-03-3109983843bus:Director22024-04-012025-03-3109983843bus:Director32024-04-012025-03-3109983843bus:Director42024-04-012025-03-3109983843bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3109983843bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP